640 related articles for article (PubMed ID: 17583173)
1. Carvedilol in the treatment of chronic heart failure: lessons from the Carvedilol Or Metoprolol European Trial.
Kveiborg B; Major-Petersen A; Christiansen B; Torp-Pedersen C
Vasc Health Risk Manag; 2007; 3(1):31-7. PubMed ID: 17583173
[TBL] [Abstract][Full Text] [Related]
2. Commentary on the Carvedilol or Metoprolol European Trial (COMET).
Poole-Wilson PA
Am J Cardiol; 2004 May; 93(9A):40B-2B. PubMed ID: 15144936
[TBL] [Abstract][Full Text] [Related]
3. Exchange of beta-blockers in heart failure patients. Experiences from the poststudy phase of COMET (the Carvedilol or Metoprolol European Trial).
Di Lenarda A; Remme WJ; Charlesworth A; Cleland JG; Lutiger B; Metra M; Komajda M; Torp-Pedersen C; Scherhag A; Swedberg K; Poole-Wilson PA;
Eur J Heart Fail; 2005 Jun; 7(4):640-9. PubMed ID: 15921806
[TBL] [Abstract][Full Text] [Related]
4. Effects of metoprolol and carvedilol on cause-specific mortality and morbidity in patients with chronic heart failure--COMET.
Torp-Pedersen C; Poole-Wilson PA; Swedberg K; Cleland JG; Di Lenarda A; Hanrath P; Komajda M; Lutiger B; Metra M; Remme WJ; Scherhag A; Skene A;
Am Heart J; 2005 Feb; 149(2):370-6. PubMed ID: 15846279
[TBL] [Abstract][Full Text] [Related]
5. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
Jabbour A; Macdonald PS; Keogh AM; Kotlyar E; Mellemkjaer S; Coleman CF; Elsik M; Krum H; Hayward CS
J Am Coll Cardiol; 2010 Apr; 55(17):1780-7. PubMed ID: 20413026
[TBL] [Abstract][Full Text] [Related]
6. Effects of carvedilol or metoprolol on PAI-1, tPA-mass concentration or Von Willebrand factor in chronic heart failure--a COMET substudy.
Boman K; Jansson JH; Nilsson T; Swedberg K; Cleland JG; Poole-Wilson P
Thromb Res; 2010 Feb; 125(2):e46-50. PubMed ID: 19762071
[TBL] [Abstract][Full Text] [Related]
7. [The COMET study compares effect of two different beta-blockers in chronic heart failure. Carvedilol better than metoprolol].
Swedberg K
Lakartidningen; 2003 Sep; 100(37):2852-4. PubMed ID: 14558169
[No Abstract] [Full Text] [Related]
8. Do beta-blockers prolong survival in heart failure only by inhibiting the beta1-receptor? A perspective on the results of the COMET trial.
Packer M
J Card Fail; 2003 Dec; 9(6):429-43. PubMed ID: 14966782
[TBL] [Abstract][Full Text] [Related]
9. [A randomized comparison of carvedilol and metoprolol in patients with chronic heart failure. The Carvedilol Or Metoprolol European Trial (COMET) ].
Torp-Pedersen CT;
Ugeskr Laeger; 2004 Aug; 166(32):2671-4. PubMed ID: 15347171
[No Abstract] [Full Text] [Related]
10. Pharmacodynamics of beta-blockers in heart failure: lessons from the carvedilol or metoprolol European trial.
Bauman JL; Talbert RL
J Cardiovasc Pharmacol Ther; 2004 Jun; 9(2):117-28. PubMed ID: 15309248
[TBL] [Abstract][Full Text] [Related]
11. Effects of metoprolol and carvedilol on pre-existing and new onset diabetes in patients with chronic heart failure: data from the Carvedilol Or Metoprolol European Trial (COMET).
Torp-Pedersen C; Metra M; Charlesworth A; Spark P; Lukas MA; Poole-Wilson PA; Swedberg K; Cleland JG; Di Lenarda A; Remme WJ; Scherhag A;
Heart; 2007 Aug; 93(8):968-73. PubMed ID: 17237130
[TBL] [Abstract][Full Text] [Related]
12. Carvedilol protects better against vascular events than metoprolol in heart failure: results from COMET.
Remme WJ; Torp-Pedersen C; Cleland JG; Poole-Wilson PA; Metra M; Komajda M; Swedberg K; Di Lenarda A; Spark P; Scherhag A; Moullet C; Lukas MA
J Am Coll Cardiol; 2007 Mar; 49(9):963-71. PubMed ID: 17336720
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and pharmacodynamics of beta blockers in heart failure.
Talbert RL
Heart Fail Rev; 2004 Apr; 9(2):131-7. PubMed ID: 15516861
[TBL] [Abstract][Full Text] [Related]
14. Has COMET solved the controversy as to whether carvedilol is better than metoprolol in heart failure?
Doggrell SA
Expert Opin Pharmacother; 2004 Jan; 5(1):205-8. PubMed ID: 14680448
[TBL] [Abstract][Full Text] [Related]
15. Beta-blocker treatment of chronic heart failure: comparison of carvedilol and metoprolol.
Maack C; Elter T; Böhm M
Congest Heart Fail; 2003; 9(5):263-70. PubMed ID: 14564145
[TBL] [Abstract][Full Text] [Related]
16. A comparison of the effects of carvedilol and metoprolol on well-being, morbidity, and mortality (the "patient journey") in patients with heart failure: a report from the Carvedilol Or Metoprolol European Trial (COMET).
Cleland JG; Charlesworth A; Lubsen J; Swedberg K; Remme WJ; Erhardt L; Di Lenarda A; Komajda M; Metra M; Torp-Pedersen C; Poole-Wilson PA;
J Am Coll Cardiol; 2006 Apr; 47(8):1603-11. PubMed ID: 16630997
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive adrenergic receptor blockade with carvedilol is superior to beta-1-selective blockade with metoprolol in patients with heart failure: COMET.
Cleland JG
Curr Heart Fail Rep; 2004 Jul; 1(2):82-8. PubMed ID: 16036030
[TBL] [Abstract][Full Text] [Related]
18. Rationale and design of the carvedilol or metoprolol European trial in patients with chronic heart failure: COMET.
Poole-Wilson PA; Cleland JG; Di Lenarda A; Hanrath P; Komajda M; Metra M; J Remme W; Swedberg K; Torp-Pedersen C
Eur J Heart Fail; 2002 Jun; 4(3):321-9. PubMed ID: 12034158
[TBL] [Abstract][Full Text] [Related]
19. Do metoprolol and carvedilol have equivalent effects on diurnal heart rate in patients with chronic heart failure?
Sanderson JE; Leung LY; Chan SK; Yip GW; Fung JW; Yu CM
Eur J Heart Fail; 2005 Aug; 7(5):874-7. PubMed ID: 16043407
[TBL] [Abstract][Full Text] [Related]
20. Beta-receptor selectivity of carvedilol and metoprolol succinate in patients with heart failure (SELECT trial): a randomized dose-ranging trial.
Zebrack JS; Munger M; Macgregor J; Lombardi WL; Stoddard GP; Gilbert EM
Pharmacotherapy; 2009 Aug; 29(8):883-90. PubMed ID: 19637941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
